Yet we still lack state-resolved, base-level maps of RNA modifications within CAF subtypes, making it unclear whether iCAFs preferentially export writers while myCAFs rely on paracrine induction of tumor METTL3—or whether specific readers (IGF2BPs vs. YTHDFs) dominate in each niche. The gene discussed is METTL3; the disease is neoplasm.